| 1 |
Healthcare |
| |
| |
Koby Yeshayahou and Guy |
02/05/2012 |
| | Analysts see a huge upside in Protalix Biotherapeutics Inc. (AMEX: PLX ; TASE: PLX ) share price after the drug development company received FDA approval to market its Elelyso treatment for Gaucher (... |
| 2 |
Healthcare |
| |
| |
Koby Yeshayahou |
02/05/2012 |
| | BiondVax Pharmaceuticals Ltd. (TASE: BNDX ) has reported this morning that the National Institutes of Health (NIH), an agency of the US Department of Health, is examining possible clinical cooperation... |
| 3 |
Healthcare |
| |
| |
Gali Weinreb and Koby |
02/05/2012 |
| | The US Food and Drug Administration (FDA) has approved for marketing in the US Protalix Biotherapeutics Inc. (AMEX: PLX ; TASE: PLX ) drug Elelyso for the treatment of Gaucher disease. The approval ... |
| 4 |
Healthcare |
| |
| |
Globes correspondent |
01/05/2012 |
| | Stem cell company Pluristem Therapeutics Ltd. (Nasdaq: PSTI ; DAX: PJT: PLTR ) says that its subsidiary Pluristem Ltd., has received approval for a NIS11.8 million ($3.1 million) grant from the Office... |
| 5 |
Healthcare |
| |
| |
Globes correspondent |
01/05/2012 |
| | Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA ; TASE: TEVA ) announced that it has settled patent infringement litigation regarding the US patent of Mylan Inc.'s ANDA for Teva’s wakefulness Teva ... |
| 6 |
Healthcare |
| |
| |
Hillel Koren |
01/05/2012 |
| | The US Food and Drug Administration (FDA) is due to decide today whether to approve the treatment developed by Protalix Biotherapeutics Inc. (AMEX: PLX ; TASE: PLX ) for Gaucher's disease, Ulypso. "... |
| 7 |
Healthcare |
| |
| |
Gali Weinreb |
01/05/2012 |
| | PhotoMedex Inc. (Nasdaq: PHMD ; TASE: PHMD ) has had its application approved to dual-list for trading on the Tel Aviv Stock Exchange (TASE). It will begin trading on the TASE on May 3. PhotoMedex is... |
| 8 |
Healthcare |
| |
| |
Gali Weinreb |
01/05/2012 |
| | Despite apparently positive figures of a 600% rise in sales last year, and declarations by the largest shareholder, Mori Arkin (41%) that he will inject NIS 10 million into the company on condition (... |
| 9 |
Healthcare |
| |
| |
Gali Weinreb |
30/04/2012 |
| | InsuLine Medical Ltd. (TASE: INSL ), which has developed a device that expedites the absorption of insulin in diabetes patients, has raised NIS 5.6 million from the Pontifax fund. The investment is at... |
| 10 |
Healthcare |
| |
| |
Gali Weinreb |
30/04/2012 |
| | Global medical devices giant Covidien plc (NYSE: COV) has acquired PolyTouch Medical Ltd., which develops hernia mesh placement technologies. The acquisition took place in 2011 but is only being (SWX... |
